EC Neurology

Research Article Volume 16 Issue 2 - 2024

Prescription Patterns in Patients with Idiopathic Parkinson’s Disease: An Ambispective Study from Northern Rajasthan of Indian Subcontinent

Himanshu Kaushal1*, Rajendra Kumar Sureka2, Amit Agarwal3 and Jatinkumar Jain1

1Senior Resident, Department of Neurology, Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan, India 2Professor Emeritus, Department of Neurology, Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan, India 3Professor and Head, Department of Neurology, Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan, India

*Corresponding Author: Himanshu Kaushal, Senior Resident, Department of Neurology, Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan, India.
Received: February 04, 2024; Published: February 24, 2024



Background: Idiopathic Parkinson’s Disease (IPD) is one of the most common neurodegenerative movement disorders having a constellation of motor as well as non-motor symptoms. The treatment of IPD has few common drugs however the prescription patterns and treatment protocols vary between different hospitals as well as physicians. The purpose of the current study was to assess and analyse the prescription patterns regarding IPD.

Materials and Methods: Type: Ambispective (retrospective and prospective) study. Sample size: 150. Patients duration: 2018 to 2023. Inclusion criteria: 1) Patients fulfilling the criteria for Idiopathic Parkinson Disease, 2) Willingness of patients to participate in the study. Exclusion criteria: 1) Patients not fulfilling the criteria for idiopathic Parkinson disease, 2) Secondary and Atypical PD, 3) Patients not willing to participate in the study. One prescription was analysed per patient. Prescriptions from outside and within the hospital were included. The first prescription was taken into account in all the patients for uniformity. Along with the prescriptions, demographic and clinical profile was taken into account. The data was entered in MS Excel and results were analysed using SPSS 20.

Results: Mean age of patients was 57.3 years. 89 (59.33%) were males and 61 (40.67%) were females. The Mean age of onset of the disease was 52.9 years and the mean duration of the disease was 3.21 years. Mean UPDRS score was 68.88. 59 (39.33%) patients were in stage 1 - 1.5 Modified Hoehn and Yahr scale, 46 (30.67%) patients had stage 2 - 2.5, 29 (19.33%) in stage 3, 13 (8.6%) in stage 4 and 3 (2%) patients in stage 5. Out of 150 patients, 12 (8%) patients were on monotherapy. 68 (45.33%) patients were on dual therapy. 43 (28.67%) patients were triple drug therapy and 27 (18%) were on polytherapy. 82.4% patients were on medication prescribed from neurologist or movement disorder specialist whereas rest of the prescriptions from general physicians.

Conclusion: There is a trend of prescription of dopaminergic agonists and levodopa as monotherapy. Novel agents like Levodopa intestinal gel or apomorphine are not being used. While prescribing factors like age of onset, duration of illness, motor or non-motor symptoms, dyskinesias, cognitive decline, tolerance to medicines and last but not the least affordability and availability should be taken into account while prescribing treatment to patients with Parkinson disease.

 Keywords: Idiopathic Parkinson’s Disease (IPD); Movement Disorders; Dyskinesias; Cognitive Decline

  1. Baumann CR., et al. “Body side and predominant motor features at the onset of Parkinson's disease are linked to motor and nonmotor progression”. Movement Disorders 2 (2014): 207-213.
  2. S Sveinbjornsdottir. “The clinical symptoms of Parkinson’s disease”. Journal of Neurochemistry 1 (2016): 318-324.
  3. Amar BR., et al. “A clinical profile of patients with Parkinson's disease and psychosis”. Annals of Indian Academy of Neurology 2 (2014): 187-192.
  4. Manorenj S. “Clinical profile of patients with Parkinson disease in Hyderabad”. International Journal of Scientific Research8 (2019): 11-14.
  5. Bamon A., et al. “A clinico-epidemiological profile of Parkinson’s disease patients attending the tertiary care hospital of hilly state of North India: A hospital based cross-sectional study”. International Journal of Research in Medical Sciences8 (2021): 2397-2400.
  6. Olanow CW., et al. “An algorithm (decision tree) for the management of Parkinson’s disease (2001): treatment guidelines”. Neurology6 (2001): S1-S88.
  7. Miyasaki JM., et al. “Practice parameter: initiation of treatment for Parkinson’s disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology”. Neurology1 (2002): 11-17.
  8. Surathi P, et al. “Prescribing pattern for Parkinson’s disease in Indian community before referral to tertiary center”. Canadian Journal of Neurological Sciences 6 (2017): 705-710.
  9. Olanow CW, et al. “The scientific and clinical basis for the treatment of Parkinson disease”. Neurology21 (2009): S1-136.

Himanshu Kaushal., et al. “Prescription Patterns in Patients with Idiopathic Parkinson’s Disease: An Ambispective Study from Northern Rajasthan of Indian Subcontinent”. EC Neurology  16.2 (2024): 01-05.